Trends in incidence of thyroid cancer in Fuling District from 2016 to 2020
WANG Yangfeng1, LIU Jun2
1. Department of Chronic Disease Control, Fuling Center for Disease Control and Prevention, Chongqing 408000, China; 2. Fuling Hospital affiliated to Chongqing University, Chongqing 408000, China
Abstract：Objective To analyze the trends in incidence of thyroid cancer in Fuling District, Chongqing Municipality from 2016 to 2020 and predict the incidence of thyroid cancer from 2021 to 2023, so as to provide insights into thyroid cancer control. Methods The data pertaining to incidence of thyroid cancer in Fuling District from 2016 to 2020 were collected through National Central Cancer Registry of China. The crude incidence rate ( CR ) of thyroid cancer, the standardized incidence rate of thyroid cancer by Chinese standard population ( ASR China ) and by world standard population ( ASR world ) were calculated. The trend in thyroid cancer incidence was analyzed using annual percent change ( APC ). The GM ( 1, 1 ) grey model was created to predict the crude incidence of thyroid cancer in Fuling District from 2021 to 2023, and the fitting effect and predictive accuracy of the model were evaluated using posterior error ratio ( C ), small probability error ( p ) and mean absolute percent error ( MAPE ). Result A total of 686 new cases of thyroid cancer were reported in Fuling District from 2016 to 2020, with CR of 11.84/105, ASR China of 11.93/105 and ASR world of 10.02/105. Among the 686 new cases of thyroid cancer, there were 165 male cases, with CR of 5.69/105, ASR China of 5.66/105 and ASR world of 4.81/105, and 521 female cases, with CR of 18.02/105, ASR China of 18.17/105 and ASR world of 15.24/105. The CR appeared a tendency towards a rise among the whole population and women in Fuling District from 2016 to 2021, with APC values of 38.40% ( t=3.369, P=0.043 ) and 38.68% ( t=4.035, P=0.027 ). The incidence of thyroid cancer peaked among patients at ages of 25 to 34 years and 50 to 54 years, with CR of 22.82/105 and 39.06/105, respectively. The GM ( 1, 1 ) grey model was qualified to fit the incidence of thyroid cancer among the whole population ( C=0.56, p=0.75 ) and women ( C=0.53, p=1.00 ). In addition, the CR of thyroid cancer was predicted to be 19.48/105, 22.51/105 and 26.03/105 ( MAPE=9.93% ) among the whole population, and 31.43/105, 37.37/105 and 44.46/105 ( MAPE=11.30% ) among women, respectively. Conclusions The incidence of thyroid cancer appeared a tendency towards a rise in Fuling District from 2016 to 2021, and is projected to increase among the whole population and women from 2021 to 2023. Women and the elderly are at high risk of thyroid cancer.
王杨凤, 刘君. 2016—2020年涪陵区甲状腺癌发病趋势[J]. 预防医学, 2022, 34(5): 511-514.
WANG Yangfeng, LIU Jun. Trends in incidence of thyroid cancer in Fuling District from 2016 to 2020. Preventive Medicine, 2022, 34(5): 511-514.
[1] 董芬,张彪,单广良.中国甲状腺癌的流行现状和影响因素[J].中国癌症杂志,2016,26(1):47-52. DONG F,ZHANG B,SHAN G L.Distribution and risk factors of thyroid cancer in China[J].China Oncol,2016,26(1):47-52. [2] 刘宗超,李哲轩,张阳,等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2021,7(2):1-13. LIU Z C,LI Z X,ZHANG Y,et al.Interpretation on the report of Global Cancer Statistics[J].J Multidiscipl Cancer Manag (Electron Version),2021,7(2):1-13. [3] 丁贤彬,吕晓燕.2006—2014年重庆市甲状腺癌发病率及趋势变化[J].中国慢性病预防与控制,2016,24(5):321-324. DING X B,LÜ X Y.Morbidities and trend of thyroid cancer from 2006 to 2014 in Chongqing city[J].Chin J Prev Contr Chron Dis,2016,24(5):321-324. [4] 张洁,闫贻忠,王丹,等.2005—2014年中国肿瘤登记地区甲状腺癌发病的时间趋势分析[J].现代预防医学,2020,47(4):577-582. ZHANG J,YAN Y Z,WANG D,et al.Time trend analysis of thyroid cancer incidence in tumor registration areas of China from 2005 to 2014[J].Mod Prev Med,2020,47(4):577-582. [5] 陈青山,王声湧,迟桂波,等.应用EXCEL完成性病GM模型的预测和评价[J].中华疾病控制杂志,2003,7(5):451-453. CHEN Q S,WANG S Y,CHI G B,et al.Prediction and evaluation of GM model by Excel[J].Chin J Dis Control Prev,2003,7(5):451-453. [6] 许连升,苏成豪,伍啸青,等.2010—2017年厦门市肺癌发病趋势分析及预测[J].现代预防医学,2021,48(2):215-218. XU L S,SU C H,WU X Q,et al.Trend analysis and prediction of lung cancer incidence during 2010 and 2017 in Xiamen[J].Mod Prev Med,2021,48(2):215-218. [7] 颜康康,林雪君,鲍红红,等.灰色GM(1,1)模型在艾滋病、淋病、梅毒发病率预测研究中的应用[J].实用预防医学,2015,22(3):371-374. YAN K K,LIN X J,BAO H H,et al.Application of GM(1,1) gray model in predicting the incidence of AIDS,gonorrhea and syphilis[J].Pract Prev Med,2015,22(3):371-374. [8] 国家癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社,2016. National Cancer Center.Chinese guideline for cancer registration(2016)[M].Beijing:People's Medical Publishing House,2016. [9] 刘芮,陈杨,石青萍,等.云南省肿瘤登记地区2012—2016年甲状腺癌发病与死亡特征及时间趋势[J].实用肿瘤学杂志,2021,35(6):489-494. LIU R,CHEN Y,SHI Q P, et al.Characteristics and time trend of thyroid cancer incidence and mortality from 2012 to 2016 in cancer registration areas of Yunnan province[J].Pract Oncol J,2021,35(6):489-494. [10] 杨雷,郑荣寿,王宁,等.2010年中国甲状腺癌发病与死亡情况[J].中华预防医学杂志,2014,48(8):663-668. YANG L,ZHENG R S,WANG N,et al.Analysis of incidence and mortality of thyroid cancer in China,2020[J].Chin J Prev Med,2014,48(8):663-668. [11] 张志焕,赵海峰.甲状腺癌发病相关危险因素的病例对照研究[J].中国药物与临床,2021,21(9):1478-1480. ZHANG Z H,ZHAO H F.A case control study of risk factors for thyroid cancer[J].Chin Remedies Clin,2021,21(9):1478-1480. [12] WANG P,LV L,QI F,et al.Increased risk of papillary thyroid cancer related to hormonal factors in women[J].Tumour Biol,2015,36(7):5127-5132. [13] 邵珠艳,王春梅,魏曼莎.灰色GM(1,1)预测模型在疾病预测中的应用[J].中国医院统计,2003,10(3):146-148. SHAO Z Y,WANG C M,WEI M S.Application of the grey system GM(1,1)forecast model on predictive diseases[J].Chin J Hosp Stat,2003,10(3):146-148.
